DOI: https://doi.org/10.22141/2224-0721.7.55.2013.84667

Use of Pulse Therapy with Methylprednisolone and Plasmapheresis in Treatment of Autoimmune Ophthalmopathy Associated with Hyperthyroidism

O.I. Chernobrova, S.V. Litvinova, V.I. Chernobrova, A.S. Ferubko, Xayuk Marua, A.V. Palamarchuk

Abstract


Results of combination treatment of active phase of autoimmune ophthalmopathy using pulse therapy with methylprednisolone and plasmaspheresis in 8 patients with hyperthyroidism (diffuse and mixed toxic goiter) are described in this article.

Keywords


autoimmune ophthalmopathy; hyperthyroidism; pulse therapy with methylprednisolone; plasmaspheresis

References


Богомазова Е.В., Мохорт Т.В. Эффективность пульс-терапии глюкокортикоидами у пациентов с аутоиммунной офтальмопатией // Клиническая и экспериментальная тиреоидология. — 2008. — № 3. — С. 44-49.

Бровкина А.Ф., Стоюхина А.С. Классификация эндокринной офтальмопатии и ее значение в выборе лечения и оценке его прогноза // Проблемы эндокринологии. — 2006. — Т. 52, № 5. — С. 11-14.

Крассас Г., Вирсинга Г.В. Современные концепции диа-гностики и лечения эндокринной офтальмопатии // Международный эндокринологический журнал. — 2007. — № 3(9). — С. 54-58.

Bradley E.A., Bartley G.B., Garrity J.A. Surgical management of Graves’ ophthalmopathy // Bahn R.S. (Ed). Thyroid Eye Disease. — Kluwer Academic Publishers, Boston, 2001. — Р. 219-34.

Marcocci C., Bartalena L., Tanda M.L. et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves’ ophthalmopathy: results of a prospective, single-blind, randomized study // J. Clin. Endocrinol. Metab. — 2001. — Vol. 86. — P. 3562-3567.

Marino M., Morabito E., Brunetto M.R. et al. Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves’ ophthalmopathy // Thyroid. — 2004. — Vol. 14. — P. 403-406.

Perros P., Krassas G.E. Orbital irradiation for thyroid-associated orbitopathy: conventional dose, low dose or no dose? // Clin. Endocrinol. (Oxf). — 2002. — Vol. 56. — P. 689-691.

Wiersinga W.M., Prummel M.F. Pathogenesis of Graves’ ophthalmopathy — current understanding // J. Clin. Endocrinol. Metab. — 2001. — Vol. 86. — P. 501-503.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2018

 

   Seo анализ сайта